Patients with severe traumatic brain injuries may be eligible to participate in an international clinical study funded by a 5-year, $3-million grant from the National Institute on Disability and Rehabilitation Research. The study is designed to test the effectiveness of a drug called amantadine hydrochloride for treating patients in vegetative and minimally conscious states.
